Latest News

Clinical trial: Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis


 

Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis is an observational study recruiting people with a history of PBC and their family members.

The trial will investigate whether or not there is a genetic factor in the development of PBC. Blood and stool samples will be taken from PBC patients and family members of PBC patients and analyzed. If a genetic component is discovered, it will add to current knowledge of how PBC and other adult chronic cholestatic liver diseases develop, as well as suggest new approaches for prevention, diagnosis, and treatment.

Individuals will be included in the study if they are aged 18-90 years old and have a history of PBC or if they are first-degree relatives of someone with PBC. Patients with PBC who have undergone a liver transplant are not excluded.

The primary outcome measure of the study is the mapping of genes that may make patients susceptible to adult chronic cholestatic liver diseases such as PBC.

The study will be completed in December 2025. About 1,500 people are expected to be included in the final analysis.

Find more information at the study page on Clinicaltrials.gov.

Recommended Reading

NLR useful for predicting 1-year mortality in PBC patients
MDedge Internal Medicine
Opioid use higher in adults with health conditions
MDedge Internal Medicine
FDA advisory panel backs safety of new hepatitis B vaccine for adults
MDedge Internal Medicine
FDA approves faster, pangenotypic cure for hep C virus
MDedge Internal Medicine
NASH did not increase risk of poor liver transplantation outcomes
MDedge Internal Medicine
Light alcohol use did not affect liver fibrosis progression in HIV/HCV-coinfected women
MDedge Internal Medicine
Statin use cuts risks in compensated cirrhosis
MDedge Internal Medicine
No obvious choice for treating pruritus in PBC patients
MDedge Internal Medicine
CREST syndrome and PBC are often associated
MDedge Internal Medicine
Hepatitis C falls as barrier to heart transplantation
MDedge Internal Medicine